An Injectable PEG-based Hydrogel Synthesized by Strain-Promoted Alkyne–azide Cycloaddition for Use As an Embolic Agent

Xin Su,Linlin Bu,Hui Dong,Shuangli Fu,Renxi Zhuo,Zhenlin Zhong

DOI: https://doi.org/10.1039/c5ra23551k

IF: 4.036

2016-01-01

RSC Advances

Abstract:Cyclooctyne and azide functionalized PEGs are prepared by ring-opening polymerization. They form a biodegradable hydrogel in situ to temporarily block rabbit ear vessels.

What problem does this paper attempt to address?

In Situ Formed Hybrid Hydrogels From Peg Based Multifunctional Hyperbranched Copolymers: A Raft Approach

Robert Kennedy,Waqar Ul Hassan,Anna Tochwin,Tianyu Zhao,Yixiao Dong,Qiang Wang,Hongyun Tai,Wenxin Wang

DOI: https://doi.org/10.1039/c3py01513k

IF: 4.6

2014-01-01

Polymer Chemistry

Abstract:Polyethylene glycol (PEG) based multifunctional hyperbranched copolymers with a high degree of vinyl functional groups were developed using RAFT polymerisation. This platform technology allowed the development of in situ crosslinkable hybrid injectable hydrogels via "click" type reactions for the delivery of human adipose derived stem cells.
Construction of an Injectable Composite Double-Network Hydrogel As a Liquid Embolic Agent.

Shili Ai,Qinzong Gao,Gele Cheng,Pengfei Zhong,Peiyu Cheng,Yingying Ren,Hao Wang,Xu Zhu,Shanyue Guan,Xiaozhong Qu

DOI: https://doi.org/10.1021/acs.biomac.3c01437

2024-01-01

Biomacromolecules

Abstract:Conventional embolists disreputably tend to recanalization arising from the low filling ratio due to their rigidity or instability. As a result, intelligent hydrogels with a tunable modulus may meaningfully improve the therapeutic efficacy. Herein, an injectable composite double-network (CDN) hydrogel with high shear responsibility was prepared as a liquid embolic agent by cross-linking poly(vinyl alcohol) (PVA) and carboxymethyl chitosan (CMC) via dynamic covalent bonding of borate ester and benzoic-imine. A two-dimensional nanosheet, i.e., layered double hydroxide (LDH), was incorporated into the network through physical interactions which led to serious reduction of yield stress for the injection of the hydrogel and the capacity for loading therapeutic agents like indocyanine green (ICG) and doxorubicin (DOX) for the functions of photothermal therapy (PTT) and chemotherapy. The CDN hydrogel could thus be transported through a thin catheter and further in situ strengthened under physiological conditions, like in blood, by secondarily cross-linking with phosphate ions for longer degradation duration and better mechanical property. These characteristics met the requirements of arterial interventional embolization, which was demonstrated by renal embolism operation on rabbits, and meanwhile favored the inhibition of subcutaneous tumor growth on an animal model. Therefore, this work makes a breakthrough in the case of largely reducing the embolism risks, thus affording a novel generation for interventional embolization.
Injectable Hydrogel Capable of In Situ Covalent Crosslinking for Permanent Embolization

Ruosen Xie,Yu-Chung Chen,Yi Zhao,Nisakorn Yodsanit,Yuyuan Wang,Naoaki Yamamoto,Dai Yamanouchi,Shaoqin Gong

DOI: https://doi.org/10.1021/acsami.1c18250

2021-11-20

Abstract:Vascular embolization provides an effective approach for the treatment of hemorrhage, aneurysms, and other vascular abnormalities. However, current embolic materials, such as metallic coils and liquid embolic agents, are limited by their inability to provide safe, consistent, and controlled embolization. Here, we report an injectable hydrogel that can remain at the injection site and subsequently undergo in situ covalent crosslinking, leading to the formation of a dual-crosslinking network (DCN) hydrogel for endovascular embolization. The DCN hydrogel is simple to prepare, easy to deploy via needles and catheters, and mechanically stable at the target injection site, thereby avoiding embolization of nontarget vessels. It possesses efficient hemostatic activity and good biocompatibility. The DCN hydrogel is also clearly visible under X-ray imaging, thereby allowing for targeted embolization. In vivo tests in a rabbit artery model demonstrates that the DCN hydrogel is effective in achieving immediate embolization of the target artery with long-term occlusion by inducing luminal fibrosis. Collectively, the DCN hydrogel provides a viable, biocompatible, and cost-effective alternative to existing embolic materials with clinical translation potential for endovascular embolization.

materials science, multidisciplinary,nanoscience & nanotechnology
An injectable and fast-degradable poly(ethylene glycol) hydrogel fabricated via bioorthogonal strain-promoted azide–alkyne cycloaddition click chemistry

huafang jiang,siyong qin,hui dong,qi lei,xin su,renxi zhuo,zhenlin zhong

DOI: https://doi.org/10.1039/c5sm00508f

IF: 4.046

2015-01-01

Soft Matter

Abstract:Biocompatible and degradable injectable materials prepared via bioorthogonal reactions are highly promising for biomedical applications because they can be formed in situ and administered in a minimally invasive way. In this work, a PEG-based injectable hydrogel was fabricated via a copper-free, strain-promoted azide-alkyne cycloaddition (SPAAC) click chemistry. Azide and cyclooctyne moieties on the PEG backbones underwent a rapid click reaction to trigger the formation of the hydrogel within several minutes. Resulting from the introduction of ester groups into the cross-linked network, the hydrogel presented pH-dependent hydrolysis and biological fast degradability. Good biocompatibility of the hydrogel was verified by in vitro cytotoxicity assay and in vivo studies. The hydrogel formed in situ after subcutaneously injecting the gel precursors into Kungming (KM) mice. The implanted hydrogel caused a mild inflammatory response in vivo, and the surrounding tissues fully recovered a week after the injection. The injectable and fast-degradable hydrogel fabricated by the bioorthogonal click reaction may be useful as biomaterials such as embolic agents for interventional therapy.
Injectable Hyperbranched Poly(β-Amino Ester) Hydrogels with On-Demand Degradation Profiles to Match Wound Healing Processes

Qian Xu,Linru Guo,A. Sigen,Yongsheng Gao,Dezhong Zhou,Udo Greiser,Jack Creagh-Flynn,Hong Zhang,Yixiao Dong,Lara Cutlar,Fagang Wang,Wenguang Liu,Wei Wang,Wenxin Wang

DOI: https://doi.org/10.1039/c7sc03913a

IF: 8.4

2018-01-01

Chemical Science

Abstract:1A series of hyperbranched poly(β-amino ester) polymers have been synthesized via a Michael addition approach for the fabrication of hydrogels for wound healing.
Injectable PEG/polyester Thermogel: A New Liquid Embolization Agent for Temporary Vascular Interventional Therapy.

Hantao Yang,Kewen Lei,Feng Zhou,Xiaowei Yang,Qingzhu An,Wei Zhu,Lin Yu,Jiandong Ding

DOI: https://doi.org/10.1016/j.msec.2019.04.075

2019-01-01

Abstract:Injectable poly(ethylene glycol) (PEG)/polyester thermogels exhibit superior injectability and unique thermoreversible sol-gel transitions compared with Onyx™, which is the only liquid embolic agent approved by the U.S. Food and Drug Administration. Herein, the feasibility of an injectable methoxy PEG-poly(d,l-lactide) copolymer (mPEG-PLA) thermogel for temporary vascular interventional therapy was evaluated in the large animal (swine) model for the first time. This mPEG-PLA polymer was soluble in water at a low temperature and exhibited a reversible sol-gel transition with increasing temperature. Meanwhile, the addition of an X-ray contrast agent did not significantly affect the gelation behavior of the thermogel but did confer excellent radiopacity, allowing intraoperative X-ray imaging guidance. In vivo experiments demonstrated that compared with traditional embolic agents, the mPEG-PLA thermogel required less preparation time and could be injected more conveniently during the operation. The temporary arterial embolization was achieved after the thermogel injection, yet the blocked arteries were recanalized 1 hour post-operation. Consequently, the mPEG-PLA thermogel shows some potential as a temporary pre-surgical embolic agent for tumor resection, but further researches including enhancing mechanical strength of gel are required to improve the embolization efficacy of PEG/polyester thermogel in the future.
A rapid crosslinking injectable hydrogel for stem cell delivery, from multifunctional hyperbranched polymers via RAFT homopolymerization of PEGDA

yixiao dong,yue qin,marie dubaa,john a killion,yongsheng gao,tianyu zhao,dezhong zhou,dominik duscher,luke m geever,geoffrey c gurtner,wenxin wang

DOI: https://doi.org/10.1039/c5py00678c

IF: 4.6

2015-01-01

Polymer Chemistry

Abstract:Stem cell therapies have attracted much attention for the last few decades in the field of regenerative medicine and tissue engineering. The 3-dimensional (3D) microenvironment surrounding the transplanted stem cells plays an essential role that influences the cell fate and behaviors. Thus advanced functional biomaterials and extracellular matrix (ECM) replacements with adjustable chemical, mechanical and bioactive properties are requisites in this field. In this study, PEG-based hyperbranched multifunctional homopolymers were developed via RAFT homopolymerization of the divinyl monomer of poly(ethylene glycol) diacrylate (PEGDA). Due to its high degree of multi-acrylate functionality, the hyperbranched polyPEGDA can rapidly crosslink with a thiolated hyaluronic acid under physiological conditions and form an injectable hydrogel for cell delivery. In addition, by simply varying the synthesis conditions such as the reaction time and the ratio of the monomer to the chain transfer agent (CTA), the polymer molecular weight, acrylate functionality degree and the cyclized/hyperbranched polymeric architecture can be finely controlled in a one-step reaction. The gelation speed and the mechanical properties of this hydrogel can be easily adjusted by altering the crosslinking conditions. Rat adipose-derived stem cells (rASCs) were embedded into the in situ crosslinked hydrogels, and their cellular behavior such as the morphology, viability, metabolic activity and proliferation were fully evaluated. The results suggested that the hydrogel maintained good cell viability and it can be easily modified with other bioactive signals, which provide this injectable hydrogel delivery system with good potential for polymeric biomaterials and tissue regeneration applications.
A hybrid injectable hydrogel from hyperbranched PEG macromer as a stem cell delivery and retention platform for diabetic wound healing.

Qian Xu,Sigen A,Yongsheng Gao,Linru Guo,Jack Creagh-Flynn,Dezhong Zhou,Udo Greiser,Yixiao Dong,Fagang Wang,Hongyun Tai,Wenguang Liu,Wei Wang,Wenxin Wang

DOI: https://doi.org/10.1016/j.actbio.2018.05.039

IF: 10.633

2018-01-01

Acta Biomaterialia

Abstract:The injectable hydrogel with desirable biocompatibility and tunable properties can improve the efficacy of stem cell-based therapy. However, the development of injectable hydrogel remains a great challenge due to the restriction of crosslinking efficiency, mechanical properties, and potential toxicity. Here, we report that a new injectable hydrogel system was fabricated from hyperbranched multi-acrylated poly(ethylene glycol) macromers (HP-PEGs) and thiolated hyaluronic acid (HA-SH) and used as a stem cell delivery and retention platform. The new HP-PEGs were synthesized via in situ reversible addition fragmentation chain transfer (RAFT) polymerization using an FDA approved anti-alcoholic drug-Disulfiram (DS) as the RAFT agent precursor. HP-PEGs can form injectable hydrogels with HA-SH rapidly via thiol-ene click reaction under physiological conditions. The hydrogels exhibited stable mechanical properties, non-swelling and anti-fouling properties. Hydrogels encapsulating adipose-derived stem cells (ADSCs) have demonstrated promising regenerative capabilities such as the maintenance of ADSCs’ stemness and secretion abilities. The ADSCs embedded hydrogels were tested on the treatment of diabetic wound in a diabetic murine animal model, showing enhanced wound healing.
Injectable Hyaluronic Acid/poly(ethylene Glycol) Hydrogels Crosslinked Via Strain-Promoted Azide-Alkyne Cycloaddition Click Reaction

Shuangli Fu,Hui Dong,Xueyi Deng,Renxi Zhuo,Zhenlin Zhong

DOI: https://doi.org/10.1016/j.carbpol.2017.04.028

IF: 10.723

2017-01-01

Carbohydrate Polymers

Abstract:This paper reports injectable hyaluronic acid (HA)-based hydrogels crosslinked with azide-modified poly(ethylene glycol) (PEG) via the strain-promoted azide-alkyne cycloaddition (SPAAC) between cyclooctyne and azide groups. Cyclooctyne-modified HA (Cyclooctyne-HA) is prepared by the reaction of HA with 2-(aminoethoxy)cyclooctyne. To crosslink the modified HA, quadruply azide-terminated poly(ethylene glycol) (Azide-PEG) is designed and prepared. The mixture of Cyclooctyne-HA and Azide-PEG gelates in a few minutes to form a strong HA-PEG hydrogel. The hydrogel has fast gelation time, good strength, and slow degradation rate, because of the high reactivity of SPAAC, high crosslinking density originated from the quadruply-substituted Azide-PEG, and the good stability of the crosslinking amide bonds. In vitro cell culturing within the hydrogel demonstrated an excellent cell-compatibility. The bioorthogonality of SPAAC makes the hydrogel injectable. With good mechanical properties and biocompatibility, the hydrogel would be useful in a wide range of applications such as injection filling materials for plastic surgery.
Dynamic Agent of an Injectable and Self-Healing Drug-Loaded Hydrogel for Embolization Therapy.

Xiaqing Zhou,Yongsan Li,Shuang Chen,Ya-Nan Fu,Shihui Wang,Guofeng Li,Lei Tao,Yen Wei,Xing Wang,Jun F Liang

DOI: https://doi.org/10.1016/j.colsurfb.2018.09.016

2018-01-01

Abstract:Embolic agents are crucial for trans-catheter arterial embolization (TAE) in the treatment of various unresectable malignant tumors. Although solid particles, liquid oils, and some polymeric hydrogels have proved their capacities for embolic therapies, the low efficiency, time sensitivity, and cytotoxicity are still considered as challenges. In this study, we developed a three-component dynamic self-healing hydrogel to overcome these limitations. With the help of the Schiff-base bonding, both glycol-chitosan and carbazochrome, containing amine groups, react with dibenzaldehyde-terminated poly(ethylene-glycol) (DF-PEG), forming the dynamic self-healing hydrogels under a mild condition within 200 s. 1H NMR and rheology test were used to characterize the Schiff-base formation and mechanical strength. Controlled-release of carbazochrome from different gelator concentrations of DF-PEG was also studied. Furthermore, in vivo evaluation of the embolization on rats showed the superior embolic effects of the injectable and self-healing hydrogel. Therefore, this new dynamic agent demonstrated the potential for application as a simple, inexpensive, and tunable embolic agent for cancer treatment and drug delivery system.
A Thermoresponsive Supramolecular Copolymer Hydrogel for the Embolization of Kidney Arteries.

Xiaohuan Shi,Haijun Gao,Fengying Dai,Xuequan Feng,Wenguang Liu

DOI: https://doi.org/10.1039/c6bm00597g

2016-01-01

Biomaterials Science

Abstract:Our team has previously reported a high strength thermoplastic supramolecular polymer hydrogel. However, the hydrogel required injection temperatures outside the physiological range therefore preventing its use in a living environment. In this article, we reported a thermoresponsive supramolecular copolymer hydrogel p(N-acryloyl glycinamide-co-acrylamide) (PNAGA-PAAm), which can be injected at temperatures within the physiological range. We used rheological measurements to demonstrate that the transition temperature (upper critical solution temperature) of both the moduli and gel-sol could be finely adjusted by controlling both the ratio and concentration of the monomer. Adding iohexol (contrast agent) in PNAGA-PAAm hydrogels contributed to the decreased moduli and gel-sol transition temperature due to weakening of the hydrogen bonding interactions. The cytocompatible and hemocompatible PNAGA-PAAm sol mixed with iohexol was injected into the renal arteries of rabbits through a microcatheter at a temperature within the high biological range. The transition from the injection temperature (high biological range) to body temperature (basal for the animals) quickly solidified the embolic agent without the occurrence of dehydration, therefore overcoming the main limitation of LCST-typed poly(N-isopropylacrylamide) previously reported. Angiography and histological examination demonstrated the successful embolization of both renal arteries and no recanalization was observed after 8 weeks. The PNAGA-based supramolecular copolymer hydrogel is a novel embolic agent that allows for the occlusion of larger sized arteries in a biocompatible environment.
Injectable Block Copolymer Hydrogels for Sustained Release of a PEGylated Drug

Lin Yu,Guang Tao Chang,Huan Zhang,Jian Dong Ding

DOI: https://doi.org/10.1016/j.ijpharm.2007.07.026

IF: 6.51

2008-01-01

International Journal of Pharmaceutics

Abstract:The paper employs the spontaneous physical gelling property of a biodegradable polymer in water to prepare an injectable sustained release carrier for a PEGylated drug. A series of thermogelling PLGA-PEG-PLGA triblock copolymers were synthesized. The PEGylated camptothecin (CPT) was also prepared and employed as the model of a PEGylated drug, and the solubility of this hydrophobic drug was significantly enhanced to over 150mg/mL. The model drug was completely entrapped into the polymeric hydrogel, and the sustained release lasted for 1 month. The mechanism of the sustained release was diffusion-controlled at the first stage and then was the combination of diffusion and degradation at the late stage. In vivo anti-tumor tests in mice further confirmed the efficacy of the model PEGylated drug released from the hydrogel. This work also revealed the specificity of the PEGylated drug in such a kind of carrier systems by decreasing the critical gelling temperature and increasing the viscosity of the sol. Due to the very convenient drug formulation and highly tunable release rate, an injectable carrier platform for PEGylated drugs is thus set up.
An injectable drug-loaded hydrogel using a “clickable” amphiphilic triblock copolymer as a precursor

DOI: https://doi.org/10.1039/C5PY01383F

2015-12-01

Abstract:We developed a facile strategy to prepare an injectable drug-loaded hydrogel with chemical crosslinkages. A PCL-POEGM-PCL amphiphilic triblock copolymer was synthesized in “one pot” by a combination of polycondensation and ring-opening polymerization, which can disperse hydrophobic drugs in aqueous solution and be crosslinked by POEGMS under physiological conditions.

Chemistry,Medicine,Materials Science
Solvent Exchange Induced In Situ Formed Hydrogel as Liquid Embolic Agents

Menghui Liu,Yunzhi Wang,Yanlv Chen,Liujun Li,Yang Sun,Yongchao Li,Yajun Yuan,Pan Lu,Wenkai Zhang,Pengfei Pang,Xin Peng,Hong Shan

DOI: https://doi.org/10.1002/adfm.202305153

IF: 19

2023-08-06

Advanced Functional Materials

Abstract:Solvent exchange can induce poly (lipoic acid‐tannic acid)/tromethamine/Galinstan dimethyl sulfoxide solution transfer into a hydrogel in situ, which can effectively embolize the renal artery of a rabbit without recanalization, resulting in ischemic atrophy of the kidney and fibrotic remodeling of the renal artery. Endovascular embolization can selectively deploy embolic agents into diseased or injured blood vessels to complete the treatment. However, traditional embolic agents still face challenges, such as poor intravascular diffusivity, non‐biodegradable, unstable mechanical properties, radiolucency, and recanalization. Herein, we report a poly (lipoic acid‐tannic acid)/tromethamine/Galinstan (PLTTG) dimethyl sulfoxide (DMSO) solution‐derived hydrogel liquid embolic agent. By injecting PLTTG DMSO solution into body fluids, a PLTTG hydrogel can be formed in situ owing to the solvent exchange induced intra‐ and inter‐polymer hydrogen bonding and electrostatic interactions. Moreover, the gelation time and injection forces of the solution as well as the mechanical properties and embolic pressure of the obtained hydrogels can be adjusted by changing the concentration of PLTTG. The PLTTG hydrogel can effectively embolize the renal artery and femoral vein without recanalization and displacement in rabbit models. Furthermore, the hydrogel can embolize the ruptured femoral artery to arrest active bleeding. Owing to the advantages of the hydrogel, including adjustable gelation time, mechanical properties, viscosities, injection forces, and embolic pressure, as well as good biocompatibility and biodegradability, radiopacity, excellent embolization performance and intravascular diffusivity, easy usage, low cost, allowing it to be a potential embolic agent to treat multiple vascular diseases in clinic.

materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology
In Situ Forming Supramolecular Nanofiber Hydrogel as a Biodegradable Liquid Embolic Agent for Postembolization Tissue Remodeling

Akihiro Nishiguchi,Miho Ohta,Debabrata Palai,Shima Ito,Kensaku Mori,Ryotaro Akagi,Christophe Bajan,Guillaume Lambard,Keitaro Sodeyama,Tetsushi Taguchi

DOI: https://doi.org/10.1002/adhm.202403784

IF: 10

2024-11-09

Advanced Healthcare Materials

Abstract:Biodegradable liquid embolic agents are used in interventional radiology. A solution of gelatin modified with hydrogen‐bonding moieties can form nanofiber hydrogels in the blood for endovascular embolization. The nanofiber hydrogel system exhibits tissue‐adhesive properties to blood vessels, nonadhesive properties to catheter tubes, and biodegradability. This nanofiber hydrogel may serve as a biodegradable liquid embolic agent for interventional radiology applications. Embolic agents have been widely used to treat blood vessel abnormalities in interventional radiology as a minimally invasive procedure. However, only a few biodegradable liquid embolic agents exhibit high embolization performance, biodegradability, and operability. Herein, the design of in situ‐forming supramolecular nanofiber (SNF) hydrogels is reported as biodegradable liquid embolic agents with the assistance of Bayesian optimization through an active learning pipeline. Chemically modified gelatin with hydrogen‐bonding moieties produces fibrin‐inspired nanofiber‐based hydrogels with a high blood coagulation capacity. The low viscosity of the SNF hydrogels makes them injectable using a microcatheter, and the hydrogel shows sufficient tissue adhesion to the blood vessel walls and very weak adhesion to the catheter tubes. Moreover, the SNF hydrogels exhibit high blood compatibility, cytocompatibility, cell‐adhesive properties, and biodegradability (in vitro and in vivo). Intravascularly delivered SNF hydrogels induce embolization of rat femoral arteries. This biodegradable liquid embolic agent could be a powerful tool for interventional radiology in the treatment of various diseases, including aortic aneurysm stent grafting, gynecological diseases, and liver cancer.

nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials
A Ph-Sensitive and Biodegradable Supramolecular Hydrogel Constructed from a PEGylated Polyphosphoester-Doxorubicin Prodrug and Α-Cyclodextrin

Fei Li,Jinlin He,Mingzu Zhang,Peihong Ni

DOI: https://doi.org/10.1039/c5py00620a

IF: 4.6

2015-01-01

Polymer Chemistry

Abstract:Fabrication of in situ forming supramolecular hydrogels based on an acid-labile and PEGylated polyphosphoester-doxorubicin prodrug for injectable drug delivery carriers.
Novel Hydrogel Material As a Potential Embolic Agent in Embolization Treatments

Feng Zhou,Liming Chen,Qingzhu An,Liang Chen,Ying Wen,Fang,Wei Zhu,Tao Yi

DOI: https://doi.org/10.1038/srep32145

IF: 4.6

2016-01-01

Scientific Reports

Abstract:We report a novel graphene-oxide (GO) enhanced polymer hydrogel (GPH) as a promising embolic agent capable of treating cerebrovascular diseases and malignant tumors, using the trans-catheter arterial embolization (TAE) technique. Simply composed of GO and generation five poly(amidoamine) dendrimers (PAMAM-5), our rheology experiments reveal that GPH exhibits satisfactory mechanical strength, which resist the high pressures of blood flow. Subcutaneous experiments on Sprague-Dawley (SD) rats demonstrate the qualified biocompatibility of GPH. Finally, our in vivo experiments on New Zealand rabbits, which mix GPH with the X-ray absorbing contrast agent, Iohexol, reveal complete embolization of the artery. We also note that GPH shortens embolization time and exhibits low toxicity in follow-up experiments. Altogether, our study demonstrates that GPH has many advantages over the currently used embolic agents and has potential applications in clinical practice.
Sprayable Hydrogel for Instant Sealing of Vascular Anastomosis

Gonzalo Muñoz Taboada,Pere Dosta,Elazer R Edelman,Natalie Artzi

DOI: https://doi.org/10.1002/adma.202203087

Abstract:Bleeding-related complications following vascular surgeries occur in up to half of the patients-500 000 cases annually in the United States alone. This results in additional procedures, increased mortality rate, and prolonged hospitalization, posing a burden on the healthcare system. Commercially available materials rely, in large, on forming covalent bonds between the tissue and the biomaterial to achieve adhesion. Here, it is shown that a biomaterial based on oxidized alginate and oxidized dextran together with polyamidoamine (PAMAM) dendrimer amine provides simultaneous electrostatic and covalent interactions between the biomaterial and the tissue, maximizing adhesion. This study finds that the material withstands supraphysiological pressures (≈300 mmHg) and prevents bleeding in a rabbit aortic puncture model and in a pig carotid bilateral poly(tetrafluoroethylene) graft model-achieving superior performance to commercially available materials such as Tisseel and BioGlue. Material biocompatibility is validated in comprehensive in vitro and in vivo studies in accordance with the US Food and Drug Administration (FDA) guidelines, including in vitro neutral red uptake test, subcutaneous implantation in rabbits, ames genotoxicity, and guinea pig maximization test. This material has the potential to provide with adequate seal and reduced complications following complex vascular surgeries, including hard-to-seal tissue-graft interfaces.
Injectable enzymatically crosslinked hydrogels based on a poly(L-glutamic acid) graft copolymer

kaixuan ren,chaoliang he,yilong cheng,gao li,xuesi chen

DOI: https://doi.org/10.1039/c4py00420e

IF: 4.6

2014-01-01

Polymer Chemistry

Abstract:Enzymatically crosslinked injectable hydrogels based on poly(L-glutamic acid) grafted with tyramine and poly(ethylene glycol) (denoted as PLG-g-TA/PEG) were developed under physiological conditions in the presence of horseradish peroxidase (HRP) and hydrogen peroxide (H2O2). Their gelation time, mechanical properties, swelling behaviors and porous structure were evaluated. The hydrogels were rapidly formed in the presence of low concentrations of HRP and H2O2. The storage modulus of the hydrogels could be well controlled and increased by increasing the concentrations of HRP and H2O2. The average pore-size of the hydrogels varied from 20 to 120 mu m, depending on the H2O2 concentration. In addition, the encapsulated L929 fibroblast cells in the PLG-g-TA/PEG hydrogels exhibited high viability. After subcutaneous injection of the PLG-g-TA/PEG solutions containing HRP and H2O2 into the back of rats, the hydrogels were rapidly formed in situ. The hydrogels were found to persist for up to 10 weeks in vivo, and histological analysis indicated that the hydrogels exhibited acceptable biocompatibility. These results suggested that the biocompatible, injectable enzyme-mediated PLG-g-TA/PEG hydrogels are promising for biomedical applications including tissue engineering scaffolds and drug delivery carriers.
Radiopaque Highly Stiff and Tough Shape Memory Hydrogel Microcoils for Permanent Embolization of Arteries

Yinyu Zhang,Haijun Gao,Hao Wang,Ziyang Xu,Xiaowei Chen,Bo Liu,Yuan Shi,Ying Lu,Lianfang Wen,Yan Li,Zhisheng Li,Yongfeng Men,Xuequan Feng,Wenguang Liu

DOI: https://doi.org/10.1002/adfm.201705962

IF: 19

2018-01-01

Advanced Functional Materials

Abstract:Transcatheter arterial embolization of aneurysm with metal microcoils is notoriously prone to recanalization arising from the low filling ratio due to their extreme rigidity. Smart hydrogel microcoils with tunable modulus may essentially significantly improve the therapeutic efficacy. Here, a radiopaque highly stiff body-temperature-triggered shape memory (SM) hydrogel is fabricated for the first time by introducing reversible hydrophobic dipole pairing microdomains in the flexibly crosslinked network, followed by BaSO4 precipitation. This radiopacification does not affect their mechanical performances as well as the SM effect. It is demonstrated that the mechanical properties of SM hydrogels are comparable to those of rubbers and can be modulated by adjusting temperature ranging from 20 to 40 degrees C. Benefiting from the thermoresponsive mechanical properties, the stiff radiopaque hydrogel strip can easily pass through a catheter under the protection of cool saline for delivery into pig's renal artery, and spontaneously and rapidly transformed into a microcoil upon contacting blood. Real-time angiogram reveals that continuous delivery of several hydrogel microcoils can efficiently occlude the blood supply. The kidneys are atrophied considerably over three month postoperative follow-up, and no recanalization occurs throughout the experimental time. These novel hydrogel microcoils are promising to be developed as novel permanent embolic agents for treating aneurysm.

An Injectable PEG-based Hydrogel Synthesized by Strain-Promoted Alkyne–azide Cycloaddition for Use As an Embolic Agent

In Situ Formed Hybrid Hydrogels From Peg Based Multifunctional Hyperbranched Copolymers: A Raft Approach

Construction of an Injectable Composite Double-Network Hydrogel As a Liquid Embolic Agent.

Injectable Hydrogel Capable of In Situ Covalent Crosslinking for Permanent Embolization

An injectable and fast-degradable poly(ethylene glycol) hydrogel fabricated via bioorthogonal strain-promoted azide–alkyne cycloaddition click chemistry

Injectable Hyperbranched Poly(β-Amino Ester) Hydrogels with On-Demand Degradation Profiles to Match Wound Healing Processes

Injectable PEG/polyester Thermogel: A New Liquid Embolization Agent for Temporary Vascular Interventional Therapy.

A rapid crosslinking injectable hydrogel for stem cell delivery, from multifunctional hyperbranched polymers via RAFT homopolymerization of PEGDA

A hybrid injectable hydrogel from hyperbranched PEG macromer as a stem cell delivery and retention platform for diabetic wound healing.

Injectable Hyaluronic Acid/poly(ethylene Glycol) Hydrogels Crosslinked Via Strain-Promoted Azide-Alkyne Cycloaddition Click Reaction

Dynamic Agent of an Injectable and Self-Healing Drug-Loaded Hydrogel for Embolization Therapy.

A Thermoresponsive Supramolecular Copolymer Hydrogel for the Embolization of Kidney Arteries.

Injectable Block Copolymer Hydrogels for Sustained Release of a PEGylated Drug

An injectable drug-loaded hydrogel using a “clickable” amphiphilic triblock copolymer as a precursor

Solvent Exchange Induced In Situ Formed Hydrogel as Liquid Embolic Agents

In Situ Forming Supramolecular Nanofiber Hydrogel as a Biodegradable Liquid Embolic Agent for Postembolization Tissue Remodeling

A Ph-Sensitive and Biodegradable Supramolecular Hydrogel Constructed from a PEGylated Polyphosphoester-Doxorubicin Prodrug and Α-Cyclodextrin

Novel Hydrogel Material As a Potential Embolic Agent in Embolization Treatments

Sprayable Hydrogel for Instant Sealing of Vascular Anastomosis

Injectable enzymatically crosslinked hydrogels based on a poly(L-glutamic acid) graft copolymer

Radiopaque Highly Stiff and Tough Shape Memory Hydrogel Microcoils for Permanent Embolization of Arteries